Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.
Breast Cancer
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring chemotherapy, vaginal flora
Eligibility Criteria
Inclusion Criteria:
Only women with breast cancer and neoadjuvant / adjuvant chemotherapy, at least 4 weeks postoperative, without vaginal bleeding without abnormal vaginal discharge, Only women with Nugent scores between 4 and 6
Exclusion Criteria:
Patients with diarrhoea, constipation, vaginal or urinary tract infection requiring antibacterial treatment and women receiving antibiotic therapy in the previous 4 weeks.
Sites / Locations
- Medical University of Vienna - Department of Obstetrics and Gynecology
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Placebo
Probiotics
30 participants in this group receive a oral lactose placebo
30 participants in this group receiving oral probiotic capsules for 7 days twice daily containing four lyophilised Lactobacillus strains belonging to the species: L.rhamnosus/ LbV96 (DSM 22560) L.jensenii /LbV 116 (DSM 22567) L.crispatus/ Lbv88 (DSM 22566) L.gasseri /LbV 150N (DSM 22583)